MANAGEMENT
Our Team and Board of Directors bring proven experience from all facets of the radiopharmaceutical industry.
Please do not hesitate to contact us!
Prof. Dr. Frank Rösch
Location: Berlin Office
Frank Rösch holds a professorship at the Institute of Nuclear Chemistry, Johannes Gutenberg-University Mainz, Germany. His scientific focus is on physico-chemistry, radiochemistry and radiopharmaceutical chemistry of metallic radionuclides and their compounds in diagnostic and therapeutic application. This covers isotope production including cross sections for different nuclear reaction pathways, and radiochemical separations. The latter included new metallic positron emitters such as 86Y, 94mTc, 110mIn, 52Mn and others, intended to bridge endoradiotherapy or SPECT with analogous PET-tracers.
Several radionuclide generator systems and reactor-based nuclear reactions were investigated leading to no-carrier-added products with potential for therapeutic applications, such as 90Sr/90Y or 188W/188Re and the 176Yb(n,g)176Yb─b-®177Lu pathway. In parallel, research covers new radionuclide generator systems, providing positron emitting daughter radionuclides, such as 140Nd/140Pr, 72Se/72As, 68Ge/68Ga and 44Ti/44Sc.
Currently, all aspects of the 68Ge/68Ga and the 44Ti/44Sc generators are covered, starting from generator concepts, post-processing of generator eluates, new radiolabeling technologies, synthesis of new chelates for 68Ga and development and evaluation of new 68Ga radiopharmaceuticals such as macrocyclic bisphosphonates. In this context, DATA- and AAZTA-based chimeric chelators are a current focus, as they allow to label radiopharmaceuticals in an “instant-kit” type protocol – in analogy to the 99mTc-radiopharmaceuticals. He initiated a systematic research towards radio-theranostic compounds based on bisphosphonates.
In parallel, the group addresses 18F-chemistry directed to the synthesis and biological evaluation of 18F-labelled tracers for studying the human brain. New neurotransmitter analogues such as [18F]PR04.MZ and [18F]MH.MZ for imaging the dopamine transporter and the serotonin receptor system have been developed.
He teaches nuclear and radiochemistry and radiopharmaceutical chemistry at the Universities of Mainz and supervises Diploma, Bachelor and Master students (more than 100) from various countries and supervises PhD students (more than 60) from various countries.
He has published about 400 papers and is member of editorial boards of several scientific journals. He authored and was editor of several books, including a scientific book for professionals working with radioactivity: Vértes A, Nagy S, Klencsár Z, Lovas RG, Rösch F (eds.), Handbook of Nuclear Chemistry. Second edition, 3324 p., 6 Volumes, Springer, Berlin-Heidelberg, and two teaching books for bachelor students and professionals working with radioactivity, including nuclear medicine:
Rösch F: Nuclear and Radiochemistry. Volume I: Introduction, and Rösch F (ed): Nuclear and Radiochemistry. Volume II: Modern Applications. Walter De Gruyter, Berlin/Boston, 2014 and 2016, respectively.
Together with Prof. Richard Baum he initiated a series of World Congresses on Gallium-68 and Peptide Receptor Radionuclide Therapy (1st World Congress: Bad Berka, Germany, 2011), which now has turned into Thernanostic World Congresses.
In 2016, he was honored with the VIKRAM SARAHBAI MEMORIAL ORATION award, of the Society of Nuclear Medicine, India. This is the most important international prize awarded annually by the Society of Nuclear Medicine of India.
Luming Xiong
Location: China
Member of the expert group of the global science and technology innovation network of the United Nations Industrial Development Organization Experts of the State Administration of foreign affairs Visiting professor such as Beijing University of technology Staufen Senior Consultant Business mentors of several incubation bases in Germany and China Master of electronic engineering at the University of technology in Berlin and Master of business administration at Henley School of management, UK Several consultants of Sino German cooperation projects Master of electronic engineering at the University of technology in Berlin Master of business administration, Henley School of management in UK
CONSULTANTS
Tom Rösch
As a pharmacist professional, Tom Rösch is consulting SCV in the development and quality assurance of radiopharmaceuticals manufactured for human use under Current Good Manufacturing Practices (GMP).
Send an e-mail
After obtaining his diploma in chemistry in 2016 he started his Ph.D. at the University Hospital Würzburg in 2018, where he workes on therapeutic drug monitoring in tears.
As a pharmacist professional, Tom Rösch is consulting SCV in the development and quality assurance of radiopharmaceuticals manufactured for human use under Current Good Manufacturing Practices (GMP).
Anne Seeanner
Send an e-mail
Anne Seeanner is responsible for corporate communications and marketing activities of SCV. Here she benefits from her many years of experience in the field of b2b communication and public relations.
Please contact her to arrange interviews with the Executive Board and briefings with the SCV officials. When requesting an interview, please indicate which media organization you represent and submit a brief list of questions to be answered.
Dr. Zhiyang Wieland-Wu
Zhiyang Wieland-Wu is responsible for pharmaceutical project management of SCV.
Send an e-mail
After obtaining her diploma in biochemistry at Free University Berlin in 2017 she started his Docterate at Charité – Berlin University of Medicine, where she workes on discovery of identification tag on tumor and its stroma surface for precise and personalized diagnosis and therapy. As a biochemist professional, Zhiyang Wieland-Wu works for SCV in arrangement of pharmaceutical project from idea development to authorization in global market.